Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biofrontera Inc. stock logo
BFRI
Biofrontera
$1.08
$0.97
$0.55
$1.21
$13.83M0.81342,858 shs90,522 shs
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$0.03
$0.35
$0.03
$3.17
$3.50M0.497.01 million shsN/A
IN8bio, Inc. stock logo
INAB
IN8bio
$1.23
-0.8%
$1.47
$1.17
$2.73
$12.21M0.2251,765 shs22,194 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.38
+1.3%
$2.45
$2.09
$4.96
$14.75M0.3612,399 shs15,778 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biofrontera Inc. stock logo
BFRI
Biofrontera
+2.86%+1.89%+9.42%+1.89%+24.27%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
0.00%0.00%0.00%0.00%0.00%
IN8bio, Inc. stock logo
INAB
IN8bio
-1.59%-10.14%-13.29%-17.33%-46.09%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
+9.30%+6.33%-11.99%-16.07%-30.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biofrontera Inc. stock logo
BFRI
Biofrontera
$1.08
$0.97
$0.55
$1.21
$13.83M0.81342,858 shs90,522 shs
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$0.03
$0.35
$0.03
$3.17
$3.50M0.497.01 million shsN/A
IN8bio, Inc. stock logo
INAB
IN8bio
$1.23
-0.8%
$1.47
$1.17
$2.73
$12.21M0.2251,765 shs22,194 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.38
+1.3%
$2.45
$2.09
$4.96
$14.75M0.3612,399 shs15,778 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biofrontera Inc. stock logo
BFRI
Biofrontera
+2.86%+1.89%+9.42%+1.89%+24.27%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
0.00%0.00%0.00%0.00%0.00%
IN8bio, Inc. stock logo
INAB
IN8bio
-1.59%-10.14%-13.29%-17.33%-46.09%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
+9.30%+6.33%-11.99%-16.07%-30.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biofrontera Inc. stock logo
BFRI
Biofrontera
1.67
ReduceN/AN/A
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
0.00
N/AN/AN/A
IN8bio, Inc. stock logo
INAB
IN8bio
2.00
Hold$4.00225.20% Upside
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest GRTS, NAII, INAB, and BFRI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
IN8bio, Inc. stock logo
INAB
IN8bio
Reiterated RatingSell (E+)
7/15/2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
UpgradeSell (E+)Sell (D-)
7/3/2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
DowngradeHoldStrong Sell
6/29/2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
DowngradeSell (D-)Sell (E+)
6/4/2026
IN8bio, Inc. stock logo
INAB
IN8bio
Reiterated RatingBuy
6/1/2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
UpgradeSell (E+)Sell (D-)
5/26/2026
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
Reiterated RatingSell (E+)
5/14/2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
DowngradeSell (D-)Sell (E+)
4/27/2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
UpgradeSell (E+)Sell (D-)
(Data available from 7/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biofrontera Inc. stock logo
BFRI
Biofrontera
$41.71M0.33N/AN/A$0.90 per share1.20
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
$496K7.05N/AN/A$0.54 per share0.06
IN8bio, Inc. stock logo
INAB
IN8bio
N/AN/AN/AN/A$2.82 per shareN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$141.87M0.11N/AN/A$11.07 per share0.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$10.54M-$0.97N/A18.00N/A-25.66%-515.34%-53.91%8/12/2026 (Estimated)
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
-$138.49M-$1.24N/AN/AN/A-910.50%-328.51%-82.53%N/A
IN8bio, Inc. stock logo
INAB
IN8bio
-$19.44M-$2.61N/AN/AN/AN/A-96.39%-80.18%8/6/2026 (Estimated)
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-$13.57M-$2.39N/AN/AN/A-10.13%-12.21%-5.30%N/A

Latest GRTS, NAII, INAB, and BFRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$0.1050N/AN/AN/A$9.50 millionN/A
8/6/2026Q2 2026
IN8bio, Inc. stock logo
INAB
IN8bio
-$0.3437N/AN/AN/AN/AN/A
5/18/2026Q3 2026
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/A-$0.72N/A-$0.72N/A$35.48 million
5/14/2026Q1 2026
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$0.1150-$0.41-$0.2950-$0.41$10.25 million$10.08 million
5/7/2026Q1 2026
IN8bio, Inc. stock logo
INAB
IN8bio
-$0.59-$0.26+$0.33-$0.26N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biofrontera Inc. stock logo
BFRI
Biofrontera
N/AN/AN/AN/AN/A
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
N/AN/AN/AN/AN/A
IN8bio, Inc. stock logo
INAB
IN8bio
N/AN/AN/AN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biofrontera Inc. stock logo
BFRI
Biofrontera
0.78
1.20
1.09
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
1.83
2.54
2.54
IN8bio, Inc. stock logo
INAB
IN8bio
N/A
10.50
10.50
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.13
1.64
0.87

Institutional Ownership

CompanyInstitutional Ownership
Biofrontera Inc. stock logo
BFRI
Biofrontera
10.08%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
48.46%
IN8bio, Inc. stock logo
INAB
IN8bio
92.05%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
32.40%

Insider Ownership

CompanyInsider Ownership
Biofrontera Inc. stock logo
BFRI
Biofrontera
8.10%
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
4.61%
IN8bio, Inc. stock logo
INAB
IN8bio
14.50%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
20.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biofrontera Inc. stock logo
BFRI
Biofrontera
7012.80 million11.77 millionNo Data
Gritstone bio, Inc. stock logo
GRTS
Gritstone bio
190108.57 million111.84 millionNo Data
IN8bio, Inc. stock logo
INAB
IN8bio
209.85 million8.42 millionNot Optionable
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
2906.28 million4.97 millionNot Optionable

Recent News About These Companies

Natural Alternatives Resolves Credit Agreement Issues

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biofrontera stock logo

Biofrontera NASDAQ:BFRI

$1.08 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.08 0.00 (0.00%)
As of 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Gritstone bio stock logo

Gritstone bio NASDAQ:GRTS

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a COVID-19 vaccine program; and a therapeutic vaccine candidate that is in Phase 1 clinical trials designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

IN8bio stock logo

IN8bio NASDAQ:INAB

$1.23 -0.01 (-0.81%)
Closing price 03:59 PM Eastern
Extended Trading
$1.20 -0.02 (-2.03%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IN8bio is a clinical-stage biopharmaceutical company developing γδ T cell therapeutic and γδ T cell engager (TCE) product candidates to address unmet medical needs. γδ T cells are a specialized population of T cells that possess unique properties, including the ability to differentiate between healthy and diseased tissue. The Company's lead programs consist of INB-100, an allogeneic γδ T cell candidate for adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation. The Company is also developing INB-200/400, an autologous genetically modified γδ T cell candidate for newly diagnosed Glioblastoma (GBM). The preclinical pipeline includes a novel γδ T cell engager platform, INB-600, which activates and expands γδ T cells in vivo for deep target cell depletion and is being developed for oncology and autoimmune indications.

Natural Alternatives International stock logo

Natural Alternatives International NASDAQ:NAII

$2.38 +0.03 (+1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$2.40 +0.02 (+1.05%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.